Biocon said a US court has invalidated a Sanofi patent on the insulin glargine device.

The company has filed a police complaint regarding hostile takeover.

India was already the world’s largest exporter of generic drugs, with $16.4 bn sold abroad last year.

Sun was tipped into a loss this quarter after it agreed to pay plaintiffs including Canadian rival Apotex to settle a lawsuit over sleep-di...

According to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.

His relentless drive has helped make Sun India’s biggest drugmaker and best performing stock over 20 years - and Shanghvi the country’s 2nd...

Drug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.

The Finance Ministry today referred FDI proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee ...

Drug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.

Mylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...

The decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...

US-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...

FDI in India increased by about 16 per cent year-on-year to $ 1.44 billion in June, which is the lowest figure during the calender year.

CCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...